Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation

Clinical Pharmacology and Therapeutics
K R SweeneyP A Kramer

Abstract

Two elderly patients, who were chronically receiving aspirin, developed lethargy, incontinence, and confusion after dosing with acetazolamide. Unbound plasma acetazolamide concentrations were elevated and plasma protein binding was reduced, suggesting an interaction with aspirin. In vitro studies demonstrated a concentration-dependent effect of salicylate on acetazolamide binding to serum proteins. At a therapeutic serum acetazolamide level of 8.0 micrograms/ml, the unbound percentage of acetazolamide in serum was 3.3% and increased to 11.0% and 30.0%, with serum salicylate levels of 200 and 386 micrograms/ml, respectively. Furthermore, the apparent association constant of acetazolamide for binding to serum proteins was decreased by 58% and 86% of its control value at these respective salicylate concentrations. The maximal binding capacity of serum for acetazolamide was not affected by salicylate. Pharmacokinetic studies in four volunteers showed that the plasma protein binding and renal clearance of acetazolamide were significantly reduced during chronic salicylate dosing. Salicylate appears to competitively inhibit the plasma protein binding of acetazolamide and simultaneously to inhibit acetazolamide renal tubular secretion....Continue Reading

Citations

Jun 1, 1989·British Journal of Clinical Pharmacology·K R SweeneyP A Kramer
Feb 16, 2016·Expert Opinion on Drug Metabolism & Toxicology·Claudiu T Supuran
Sep 9, 2017·Tropical Diseases, Travel Medicine and Vaccines·Tida K LeeTimothy J Whitman
May 1, 1996·The Annals of Pharmacotherapy·W G Reiss, K S Oles
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Emilio SternieriAnna Ferrari
Oct 11, 2011·Cardiology in Review·Rahim Kassamali, Domenic A Sica
Jun 25, 2020·The New England Journal of Medicine·Biff F Palmer, Deborah J Clegg
Dec 1, 1996·Journal of the American Geriatrics Society·J R Meuleman
Jan 7, 2006·Journal of Clinical Pharmacology·Ji-Young ParkJong-Myung Ha
Mar 13, 2014·Expert Opinion on Drug Safety·Erik R Swenson
Aug 1, 1993·Journal of the American Geriatrics Society·P Rousseau, A Fuentevilla-Clifton
May 12, 2006·International Clinical Psychopharmacology·Nicoletta BrunelloJulien Mendlewicz
Jul 26, 2002·Journal of the American Society of Nephrology : JASN·Christoph SauvantMichael Gekle
Nov 1, 1992·Journal of Pharmacological and Toxicological Methods·I M Greene, A D Kenny
Aug 1, 1988·Baillière's Clinical Rheumatology·R O DayK M Williams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.